CEO & Directo, OncoHelix Inc.
Professor, Cumming School of Medicine
Director, Hematology Translational Lab
University of Calgary
Dr. Faisal M. Khan is a Professor at the University of Calgary. In his clinical role, he is the Director of the Hematology Translational lab and the Lead and Clinical Director of the Transplant Lab South (TLS) in Alberta Precision Labs.
Dr. Khan is co-founder and CEO of OncoHelix Inc., an organization that specializes in providing esoteric cancer genomic and immunology testing in Canada and UAE.
Dr. Khan obtained his Ph.D. in Human Molecular Genetics in India in 2006. He completed his postdoctoral training and clinical fellowship at the University of Calgary. Dr. Khan is a certified Diplomat of the American Board of Histocompatibility and Immunogenetics (ABHI).
Dr. Khan has over 25 years of experience in Transplant Immunology, Cancer Genomics, and Histocompatibility and Immunogenetics. Based on his research, Dr. Khan has published over 105 research articles in scientific journals like Science, Blood, Transplantation, and Blood Advances. His research has been recognized by several awards including the American Society of Hematology (ASH) Achievement Awards in 2013, 2015, and 2018; and the American Society for Histocompatibility and Immunogenetics (ASHI) Scholar/Most Clinically Relevant Study awards in 2014, 2019, 2022, and 2024.